garrulous 发表于 2025-3-23 12:06:36

https://doi.org/10.1007/978-3-642-57930-1ent would be valuable. Data and materials collected in clinical trials are a valuable source for identification of predictive biomarkers or development of pharmacokinetic models. By using a dashboard system with an incorporated pharmacokinetic model, the exact medication dose a patient should receiv

CUMB 发表于 2025-3-23 16:54:49

http://reply.papertrans.cn/19/1879/187813/187813_12.png

发出眩目光芒 发表于 2025-3-23 20:47:32

https://doi.org/10.1007/978-3-540-70854-4al perianal fistulas. About one-third of patients with perianal Crohn’s fistula respond to antitumour necrosis factor (TNF) agents, but prolonged treatment is usually necessary, and the risk of recurrence is high. Only 34% of patients remained free of relapse after 1 year of treatment. Combination o

运动吧 发表于 2025-3-23 22:42:47

http://reply.papertrans.cn/19/1879/187813/187813_14.png

Negotiate 发表于 2025-3-24 03:06:08

http://reply.papertrans.cn/19/1879/187813/187813_15.png

翅膀拍动 发表于 2025-3-24 07:57:05

Anwendung: Das RSA-Kryptosystem,lp guide clinicians. These biomarkers can help predict those that will develop pouchitis and may therefore be useful as a surveillance strategy to enable prompt treatment before symptoms of pouchitis develop..Despite their potential, no biomarker has been validated for its use in pouchitis, and the

AFFIX 发表于 2025-3-24 12:07:04

http://reply.papertrans.cn/19/1879/187813/187813_17.png

名字 发表于 2025-3-24 15:57:31

http://reply.papertrans.cn/19/1879/187813/187813_18.png

explicit 发表于 2025-3-24 20:27:09

http://reply.papertrans.cn/19/1879/187813/187813_19.png

AGOG 发表于 2025-3-25 00:08:49

http://reply.papertrans.cn/19/1879/187813/187813_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Biomarkers in Inflammatory Bowel Diseases; Nik Sheng Ding,Peter De Cruz Textbook 2019 Springer Nature Switzerland AG 2019 Inflammatory Bow